Navigation Links
Tamiflu to be examined on clinical efficacy for WHO

Roche’s flu drug Tamiflu, for bird flu, has to be examined for effectiveness in the fight against bird flu in humans. This has been called on by World Health Organization. //

WHO, in a statement from Geneva, said that no clinical evidence of the anti-viral drug's efficacy against the deadly H5N1 virus is there. Therefore urgent studies need to be undertaken.

Still, WHO also approved that Tamiflu should be used to treat suspected cases and to prevent the disease in healthcare workers or others who may have been exposed to infection.

Roche, issued a public statement that it is boosting output of Tamiflu, whose generic name is oseltamivir, by a third to meet increased demand from governments building stockpiles for a potential pandemic triggered by bird flu.

There is no direct clinical trial evidence that shows that oseltamivir is effective in human H5N1 disease because such studies have not yet been conducted, the WHO said in a statement.

The WHO commented that it was possible that severely ill patients might benefit from longer duration of therapy, for example 7-10 days, or perhaps higher doses (for example 300 mg/day), but prospective studies were required.

The WHO recommendations are based on limited data from human outbreaks, animal models, and extrapolated results of trials in patients with ordinary influenza.

Tamiflu is an antiviral drug. It is currently considered the best defence against a human pandemic that could be started by avian flu. But its efficacy has not been proved clinically.

Therefore, tamiflu would be examined for its effectiveness against bird flu
'"/>




Page: 1

Related medicine news :

1. Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid
2. India To Procure 1 Million Doses Of Tamiflu
3. US Reviews Risks Of Tamiflu After 12 Children Die
4. US Regulator Sees No Link Between Tamiflu And Japan Deaths
5. Roche confirms Tamiflu production talks in US
6. Dosage Of Tamiflu Sought To Be Increased
7. Tamiflu Fails To Save Two Lives
8. Christmas trees to yield key Tamiflu ingredient
9. India to produce Tamiflu generic ‘Oseltamivir
10. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
11. Hyderabad Firm To Manufacture Tamiflu In India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: